Nicotine pouches not yet cleared for sale in US due to concerns over young users

FDA planned to fast-track applications for authorization, but agency reviewers raise alarm over addiction risk ...
Nasdaq

OKYO Pharma Files Application for Fast Track Designation for Urcosimod in Treatment of Neuropathic Corneal Pain

OKYO Pharma Limited has filed for Fast Track designation with the U.S. FDA for its drug urcosimod, aimed at treating neuropathic corneal pain, a painful eye condition currently lacking an FDA-approved ...
Monthly Prescribing Reference

OKYO Pharma Seeks Fast Track for Urcosimod in Neuropathic Corneal Pain

Urcosimod is currently being evaluated in a phase 2 trial evaluating it's efficacy and safety in adults with neuropathic corneal pain. OKYO Pharma has filed a Fast Track designation application with ...
The Manila Times

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibrom…

Fast Track designation is one of the FDA’s expedited programs meant to facilitate development and expedite review of new ...
Seeking Alpha

BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder

ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related ...